Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
8.03
-0.07 (-0.86%)
Dec 26, 2025, 4:00 PM EST - Market closed
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $2.7 billion as of December 26, 2025. Its market cap has decreased by -47.54% in one year.
Market Cap
2.70B
Enterprise Value
2.92B
1-Year Change
-47.54%
Ranking
Category
Stock Price
$8.03
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $2.70B, an increase of 2,244.12%. That is a compound annual growth rate of 47.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 2.70B | -46.99% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | 817.72M | 196.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |